CCL2 and diabetic kidney disease: Downstream targets of NF-κB include adhesion molecules and pro-inflammatory cytokines (e.g., IL-6, TNF-α, MCP1, RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted)), which all drive the development of DKD.